OR WAIT null SECS
© 2022 MJH Life Sciences™ and Applied Clinical Trials Online. All rights reserved.
Applied Clinical Trials
ERT announced it has launched a certification program for Phase I investigative sites conducting cardiac safety studies. This program trains sites to collect precise cardiac safety data by using ERT’s proprietary Expert Precision QT approach so that trial sponsors and CROs can determine the safety of their compounds earlier in development, which can save significant time and money.
Read the full release here.